Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...
HealthDay on MSN5d
Multiple Sclerosis May Worsen With Menopause TransitionThe menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.
Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...
As a judge in Washington, D.C., considers further halting the Trump administration's freeze on federal funds, a new court ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
Mothers with multiple sclerosis had an elevated incidence and prevalence of peripartum mental illness vs. mothers without MS ...
A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...
(HealthDay News) — Mothers with multiple sclerosis (MS) have an elevated incidence and prevalence of peripartum mental illness, according to a study published online Jan. 22 in Neurology.
GlobalData on MSN12d
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis casesThe FDA reported that six patients died after being injected with Teva’s Copaxone or Sandoz’s Glatopa. The US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback